Detalhe da pesquisa
1.
Comparability assessments of process and product changes made during development of two different monoclonal antibodies.
Biologicals
; 39(1): 9-22, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20888784
2.
Application of a high-throughput screening procedure with PEG-induced precipitation to compare relative protein solubility during formulation development with IgG1 monoclonal antibodies.
J Pharm Sci
; 100(3): 1009-21, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21280052
3.
Development of a microflow digital imaging assay to characterize protein particulates during storage of a high concentration IgG1 monoclonal antibody formulation.
J Pharm Sci
; 99(8): 3343-61, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20229596
4.
Characterization of golimumab, a human monoclonal antibody specific for human tumor necrosis factor α.
MAbs
; 2(4): 428-39, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20519961
5.
Characterization of the photodegradation of a human IgG1 monoclonal antibody formulated as a high-concentration liquid dosage form.
J Pharm Sci
; 98(9): 3117-30, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19009595